Hims & Hers Health Inc HIMS

US Health Care

$27.77 ▲ +2.70% (+$0.73)

🔥 High Short Interest 🎢 High Beta 🗓️ Earnings Next Week

Open $27.48

Prev Close $27.04

Day Range $26.86 – $28.94

52W Range $13.74 – $70.43

Market Cap $6.43B

P/E (TTM) 50.07

Beta 2.44

EPS (TTM) $-0.10

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2019-09-09
Shares Out.	231,460,000
Website	forhims.com/ ↗
Phone	14158510195
Employees	2,442
Revenue	$608.1M
Gross Profit	$396.8M
Net Income	-$92.1M
Free Cash Flow	$66.9M
Total Assets	$2.27B
Total Liabilities	$1.82B
Equity	$446.2M

About Hims & Hers Health Inc

Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

Hims & Hers Health Inc is a publicly traded company under the ticker symbol HIMS on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.